Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-2018 Apply Earnings Call Transcript Q2 FY21 06th Nov 2020 Outcome of Board Meeting – 6th November 2020 06th Nov 2020 Extract of Unaudited Consolidated Financial Results – 30th September 2020 06th Nov 2020 Q2 FY21 Investor presentation 06th Nov 2020 Q2 FY21 Press release 06th Nov 2020 Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2020 06th Nov 2020 Press Release - Cipla launches ‘ELIFast’ (IgG ELISA test) for COVID-19 antibody detection 28th Oct 2020 Press Release - Cipla launches Nintib (Nintedanib capsules 100 mg, 150 mg) to treat Idiopathic Pulmonary Fibrosis, in continuation of its fight against rare lung diseases 20th Oct 2020 Earnings Conference call scheduled on 6th November 2020 19th Oct 2020 Notice of Board Meeting- Newspaper Publication 16th Oct 2020 + BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
